Amylyx Pharmaceuticals, Inc.
AMLX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $77,391 | $170,201 | $62,526 | $50,191 |
| Short-Term Investments | $99,110 | $201,161 | $284,419 | $45,927 |
| Receivables | $447 | $40,050 | $15,306 | $0 |
| Inventory | $0 | $38,323 | $9,769 | $0 |
| Other Curr. Assets | $12,484 | $14,931 | $10,113 | $8,833 |
| Total Curr. Assets | $189,432 | $464,666 | $382,133 | $104,951 |
| Property Plant & Equip (Net) | $2,732 | $6,411 | $8,135 | $474 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1,470 | $46,377 | $1,185 | $189 |
| Total NC Assets | $4,202 | $52,788 | $9,320 | $663 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $193,634 | $517,454 | $391,453 | $105,614 |
| Liabilities | – | – | – | – |
| Payables | $2,939 | $22,061 | $6,257 | $4,372 |
| Short-Term Debt | $1,518 | $2,257 | $2,040 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $23,949 | $57,724 | $38,312 | $13,024 |
| Total Curr. Liab. | $28,406 | $82,042 | $46,609 | $17,396 |
| LT Debt | $463 | $1,980 | $4,237 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $239,386 |
| Total NC Liab. | $463 | $1,980 | $4,237 | $239,386 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1,981 | $4,237 | $6,277 | $0 |
| Total Liabilities | $28,869 | $84,022 | $50,846 | $256,782 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $7 | $7 | $7 | $1 |
| Retained Earnings | -$606,692 | -$304,949 | -$354,220 | -$155,845 |
| AOCI | -$92 | $197 | -$86 | $9 |
| Other Equity | $771,542 | $738,177 | $694,906 | $4,667 |
| Total Equity | $164,765 | $433,432 | $340,607 | -$151,168 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $193,634 | $517,454 | $391,453 | $105,614 |
| Net Debt | -$75,410 | -$165,964 | -$56,249 | -$50,191 |